Fuan Pharmaceutical | Income Statement
Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
357
447
701
1,280
2,056
2,629
Cost of Goods Sold (COGS) incl. D&A
256
323
422
727
955
1,072
Gross Income
100
124
278
553
1,102
1,557
SG&A Expense
78
89
204
283
792
1,305
EBIT
20
31
67
262
307
243
Unusual Expense
-
-
-
2
6
611
Non Operating Income/Expense
3
2
5
3
6
12
Interest Expense
-
1
7
13
1
2
Pretax Income
44
54
76
257
332
331
Income Tax
6
8
11
35
49
37
Equity in Affiliates
-
-
-
-
2
8
Consolidated Net Income
39
46
66
222
285
360
Net Income
38
46
65
222
285
360
Net Income After Extraordinaries
38
46
65
222
285
360
Net Income Available to Common
38
46
65
222
285
360
EPS (Basic)
0.05
0.06
0.08
0.23
0.24
0.30
Basic Shares Outstanding
780
780
819
979
1,190
1,190
EPS (Diluted)
0.05
0.06
0.08
0.23
0.24
0.30
Diluted Shares Outstanding
780
780
819
979
1,190
1,190
EBITDA
55
78
154
383
457
385
Other Operating Expense
2
4
7
8
3
9
Non-Operating Interest Income
28
23
18
9
14
24
Minority Interest Expense
-
-
1
1
-
-
About Fuan Pharmaceutical
View Profile
